Ingrezza Sprinkle — Highmark
Chorea associated with Huntington’s disease (HD)
Initial criteria
- age ≥ 18 years
- diagnosis of chorea associated with Huntington’s disease (ICD-10: G10)
Reauthorization criteria
- prescriber attests that the member has experienced positive clinical response to therapy
Approval duration
12 months